(lp0
S'Why Puma Biotechnology Inc. Got Hammered Today Motley Fool - Mar 2, 2017 The potential to establish a new standard of care where patients take Herceptin and Perjeta for a year could be problematic for Puma Biotechnology because its drug candidate, neratinib, was tested after just Herceptin use, the current standard of care.Puma Biotech shares plummet 26% after Roche reports positive results for late ... - MarketWatch'
p1
aS"Thursday's Biotech Insights: Aurinia Pharmaceuticals Inc , Puma ... Smarter Analyst - Mar 2, 2017 Puma Biotechnology Inc  shares lost one-quarter of their value today, after competitor Roche announced positive top-line results from the highly anticipated APHINITY trial, which explores usefulness of Perjeta in adjuvant breast cancer ...Puma Biotechnology Shares Plunge On Plans To Modify Neratinib European MAA ... - Benzinga"
p2
aS'Puma Biotechnology Inc  Plunges 6.7% on March 14 Equities.com - Mar 14, 2017 Puma Biotechnology Inc  had a rough trading day for Tuesday March 14 as shares tumbled 6.7%, or a loss of $-3 per share, to close at $41.80.State Street Corp Acquires 1032915 Shares of Puma Biotechnology Inc  - The Cerbat GemThe Numeric Investors LLC Purchases New Position in Puma Biotechnology Inc  - Petro Global News 24'
p3
aS'PUMA BIOTECHNOLOGY, INC.  Files An 8-K Other Events Market Exclusive - Mar 1, 2017 Puma Biotechnology, Inc. is a biopharmaceutical company that focuses on the development and commercialization of products for the treatment of cancer.Puma Biotechnology Announces Publication of Abstracts on Neratinib for the ... - Yahoo Finance'
p4
aS'Why Puma Biotechnology Inc. Sold Lower Today Motley Fool - Oct 19, 2016 Puma Biotechnology is looking to raise $150 million selling shares, which will dilute current shareholders. Another $22.5 million of shares could also be sold within 30 days if the underwriters want the extra shares.Puma Biotechnology Inc  Swamped by New Shares - Scibility MediaPuma Biotechnology Inc  Files An 8-K - Market Exclusive'
p5
aS"Why Puma Biotechnology Inc Roared Higher Today Motley Fool - Sep 20, 2016 Puma Biotechnology  was up as much as much as 15% today after announcing that the Food and Drug Administration accepted the company's marketing application for its breast cancer drug neratinib, although it's given up some of that gain&nbsp;...JP Morgan Comments on Puma Biotechnology Inc  Following NDA Acceptance - Smarter AnalystPuma Biotechnology Announces US FDA Acceptance of New Drug Application for ... - Business Wire "
p6
aS"Puma Biotechnology  Q4 Earnings: What's in the Cards? Yahoo Finance - Feb 27, 2017 Puma Biotechnology, Inc. PBYI is expected to report fourth-quarter 2016 results next month. The company has a mixed earnings history.How Often Does Puma Biotechnology, Inc.  Miss Earnings Estimates? - Post Analyst"
p7
aS'Puma Biotechnology to Present at RBC Capital Markets Healthcare Conference Yahoo Finance - Feb 14, 2017 Puma Biotechnology, Inc. , a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of the Company at 2:05 p.m.Top Earnings Report to Watch for: Puma Biotechnology, Inc.  - The Voice Registrar'
p8
aS'Puma Biotechnology Inc  Soars 5.79% on March 07 Equities.com - Mar 7, 2017 Puma Biotechnology Inc  had a good day on the market for Tuesday March 07 as shares jumped 5.79% to close at $35.60. About 1.66 million shares traded hands on 11,693 trades for the day, compared with an average daily volume of 937,141 shares&nbsp;...RBC Capital Markets Reiterates Sector Perform Rating for Puma Biotechnology ... - Chaffey Breeze'
p9
aS'Puma Biotechnology Inc  Plunges 10.56% on February 22 Equities.com - Feb 22, 2017 Puma Biotechnology Inc  had a rough trading day for Wednesday February 22 as shares tumbled 10.56%, or a loss of $-4.05 per share, to close at $34.30.Stock Price of Puma Biotechnology Inc  Increases 10.43% - Highland MirrorHighland Capital Management LP Takes Position in Puma Biotechnology Inc  - Sports Perspectives'
p10
a.